Here's a linked in post from Kelli Stovall RPh on the pharmacy angle:
https://www.linkedin.com/feed/update/urn:li:activity:7488560277790253056/
But see also connection to Nixon Peabody 6pp memo:
Homepage:
And as 6pp pdf:
Here, memo from ATA on RTM cutbacks:
##
Don't forget the July 2026 proposals aren't in a vacuum.
See supposed risks and drawbacks of RTM from my May 2025 blog:
https://www.discoveriesinhealthpolicy.com/2025/05/remote-monitoring-peterson-center-oig.html
Note: I also have some private notes and assisted searches also from earlier in March 2026:
https://www.blogger.com/blog/post/edit/8334321271827217759/6434864259285744275